Knockdown of UbcH10 Enhances the Chemosensitivity of Dual Drug Resistant Breast Cancer Cells to Epirubicin and Docetaxel

ERK1/2 is related to oestrogen receptor and predicts outcome in hormone-treated breast cancer

(2014) Dena A. Jerjees et al.   BREAST CANCER RESEARCH AND TREATMENT

Caveolin-1 mediates chemoresistance in breast cancer stem cells via β-catenin/ABCG2 signaling pathway

(2014) Zhiyu Wang et al.   CARCINOGENESIS

cMET in triple-negative breast cancer: is it a therapeutic target for this subset of breast cancer patients?

(2014) Patricia B Gaule et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Phosphorylation of Cdc42 Effector Protein-4 (CEP4) by Protein Kinase C Promotes Motility of Human Breast Cells

(2014) Xin Zhao et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Liposomal Nitrooxy-Doxorubicin: One Step over Caelyx in Drug-Resistant Human Cancer Cells

(2014) Isabella Pedrini et al.   MOLECULAR PHARMACEUTICS

HOXD10 expression in human breast cancer

(2014) N. V. Vardhini et al.   TUMOR BIOLOGY

MicroRNA-124 inhibits cellular proliferation and invasion by targeting Ets-1 in breast cancer

(2014) Wentao Li et al.   TUMOR BIOLOGY

Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)

(2013) G. G. Steger et al.   ANNALS OF ONCOLOGY

Superior outcome after neoadjuvant chemotherapy with docetaxel, anthracycline, and cyclophosphamide versus docetaxel plus cyclophosphamide: results from the NATT trial in triple negative or HER2 positive breast cancer

(2013) Xiaosong Chen et al.   BREAST CANCER RESEARCH AND TREATMENT

Ubiquitin-conjugating enzyme E2C: A potential cancer biomarker

(2013) Chanlu Xie et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

UbcH10 expression provides a useful tool for the prognosis and treatment of non-small cell lung cancer

(2012) Liming Zhao et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Immunohistochemical Analysis of the Ubiquitin-conjugating Enzyme UbcH10 in Lung Cancer

(2012) Ida Perrotta et al.   JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY

RNA interference-mediated silencing of UBCH10 gene inhibits colorectal cancer cell growthin vitroandin vivo

(2010) Shi-Min Chen et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Overexpression of the E2 ubiquitin–conjugating enzyme UbcH10 causes chromosome missegregation and tumor formation

(2010) Janine H. van Ree et al.   JOURNAL OF CELL BIOLOGY

Clinicopathological relevance of UbcH10 in breast cancer

(2008) Takeo Fujita et al.   CANCER SCIENCE